1. bookVolumen 41 (2020): Heft 1 (June 2020)
08 Sep 2014
2 Hefte pro Jahr
Uneingeschränkter Zugang

Oral Lichen Planus – Related Connection with HLA-System Antigens

Online veröffentlicht: 22 Jun 2020
Volumen & Heft: Volumen 41 (2020) - Heft 1 (June 2020)
Seitenbereich: 65 - 77
08 Sep 2014
2 Hefte pro Jahr

1. Giannetti L, Dello Diago AM, Spinas E. Oral Lichen planus.J BiolRegulHomeost Agents. 2018 Mar–Apr; 32(2): 391–395.Search in Google Scholar

2. Rock A, Wilkinson DS, Ebling FJ. Lichen planus and lichenoid eruptions. In: Textbook of dermatology,1972; 2: 1933–64.Search in Google Scholar

3. Shklar G, Brackett CA. Common oral mucosal diseases. Med Times. 1981 Jun; 109(6): 33–40.Search in Google Scholar

4. Warin RP, Crabb HS, Darling AI. Lichen planus of the mouth. Br Med J. 1958 Apr 26; 1(5077): 983–4.10.1136/bmj.1.5077.983Search in Google Scholar

5. Regezi JA, Ellis CN, Stewart JC, Giustina TA.Histologic changes associated with the topical use of isotretinoin on oral lichen planus. Oral Surg Oral Med Oral Pathol. 1986 May; 61(5): 479–8410.1016/0030-4220(86)90391-9Search in Google Scholar

6. Shklar G, Flynn E, Szabo G. Basement membrane alterations in oral lichen planus. J Invest Dermatol. 1978 Jan; 70(1): 45–50. No abstract available.10.1111/1523-1747.ep12543477Search in Google Scholar

7. Powell ML, Ehrlich A, Belsito DV.Lichenoid drug eruption to salsalate. J Am Acad Dermatol. 2001 Oct; 45(4): 616–9.10.1067/mjd.2001.114593Search in Google Scholar

8. Dogan S, Kılınç E, Özaygen GE, Atakan N, Gököz Ö, Evans SE.Childhood–Onset Keratosis Lichenoides Chronica Accompanied by Severe Hair Loss. Skinmed. 2017 Jun 1; 15(3): 211–213. E Collection 2017.Search in Google Scholar

9. Bécherel PA, Bussel A, Chosidow O, Rabian C, Piette JC, Francès C.Extracorporeal photochemotherapy for chronic erosive lichen planus.Lancet. 1998 Mar 14; 351(9105): 805.10.1016/S0140-6736(05)78932-7Search in Google Scholar

10. Guyot AD, Farhi D, Ingen–Housz–Oro S, Bussel A, Parquet N, Rabian C, Bachelez H, FrancèsC. Treatment of refractory erosive oral lichen planus with extracorporeal photochemotherapy: 12 cases.Br J Dermatol. 2007 Mar; 156(3): 553–6.10.1111/j.1365-2133.2006.07647.xSearch in Google Scholar

11. Sodaify M, Vollum DI.Familial lichen planus.A case report.Br J Dermatol. 1978 May; 98(5): 579–8110.1111/j.1365-2133.1978.tb01946.xSearch in Google Scholar

12. Lowe NJ, Cudworth AG, Woodrow JC. HL–A antigens in lichen planus. Br J Dermatol. 1976 Aug; 95(2): 169–71.10.1111/j.1365-2133.1976.tb00821.xSearch in Google Scholar

13. Поповска М. Имунолошки аспекти на орал-ниот лихен планус. Докторска дисертација, Стоматолошки факултет. Скопје, 2000.Search in Google Scholar

14. Simon JC, Dietrich A, Mielke V, Wuttig C, Vanscheidt W, Linsley PS, Schöpf E, Sterry W. Expression of the B7/BB1 activation antigen and its ligand CD28 in T–cell–mediated skin diseases. J Invest Dermatol. 1994 Oct; 103(4): 539–43.10.1111/1523-1747.ep12395743Search in Google Scholar

15. Regezi JA, Stewart JC, Lloyd RV, Headington JT.Immunohistochemical staining of Langerhans cells and macrophages in oral lichen planus. Oral Surg. Oral Med Oral Pathol. 1985 Oct; 60(4): 396–402.10.1016/0030-4220(85)90262-2Search in Google Scholar

16. Regezi JA, Deegan MJ, Hayward JR.Lichen planus: immunologic and morphologic identification of the submucosal infiltrate.Oral Surg Oral Med Oral Pathol. 1978 Jul; 46(1): 44–52.10.1016/0030-4220(78)90436-XSearch in Google Scholar

17. Powell FC, Rogers RS, Dickson ER, Moore SB. An association between HLA DRI and lichen planus. Br J Dermatol. 1986 Apr; 114(4): 473–8.10.1111/j.1365-2133.1986.tb02852.xSearch in Google Scholar

18. Femiano F, De Crescenzo I, Battista C, Busciolano M. [HLA (Human Leukocyte Antigens) and oral immunological diseases]. Minerva Stomatol. 2001 Jan–Feb; 50(1–2): 21–30.Search in Google Scholar

19. Malmström M, Fyhrquist F, Kosunen TU, Tasanen A. Immunological features of patients with chronic sclerosing osteomyelitis of the mandible. Int J Oral Surg. 1983 Feb; 12(1): 6–13.10.1016/S0300-9785(83)80074-XSearch in Google Scholar

20. Copeman PW, Tan RS, Timlin D, Samman PD. Familial lichen planus. Another disease or a distinct people? Br J Dermatol. 1978 May; 98(5): 573–7.10.1111/j.1365-2133.1978.tb01945.x656330Search in Google Scholar

21. Hedberg NM, Hunter N. The expression of HLA–DR on keratinocytes in oral lichen planus. J Oral Pathol. 1987 Jan; 16(1): 31–5.10.1111/j.1600-0714.1987.tb00673.x2435876Search in Google Scholar

22. Watanabe T, Ohishi M, Tanaka K, Sato H. Analysis of HLA antigens in Japanese with oral lichen planus. J Oral Pathol. 1986 Nov; 15(10): 529–33.10.1111/j.1600-0714.1986.tb00571.x3104559Search in Google Scholar

23. Sun A, Wu YC, Wang JT, Liu BY, Chiang CP. Association of HLA–te22 antigen with anti–nuclear antibodies in Chinese patients with erosive oral lichen planus. Proc Natl Sci Counc Repub China B. 2000 Apr; 24(2): 63–9.Search in Google Scholar

24. Поповска М. Лихен планус клинички манифестации и неговата имуногенетска асоцираност со антигените од ХЛА–системот. Магистерски труд, 1991, Стомаолошки факултет, Скопје.Search in Google Scholar

25. Bombeccari GP, Guzzi G, Tettamanti M, et al. Oral lichen planus and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 112: 328–334.[PubMed]10.1016/j.tripleo.2011.04.00921782485Search in Google Scholar

26. Al–Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103: S25.e1–S25.e12. [PubMed]10.1016/j.tripleo.2006.11.00117261375Search in Google Scholar

27. Joanne Soo, BS, George Kokosis, Michael Ogilvie, Xiaoyin Sara Jiang, David B. Powers, Daniel J. Rocke JD, Detlev Erdmann, A Rare Case of Malignant Transformation of Oral Lichen Planus of the Mandible. Plast Reconstr Surg Glob Open. 2016 Dec; 4(12): e1070.10.1097/GOX.0000000000001070522263728293492Search in Google Scholar

28. Koberg W, Schettler D, Selle G. [On the problem of the development of a carcinoma as a sequel of lichen ruber planus of the oral mucous membrane]. Munch Med Wochenschr. 1965; 107: 463–466.[PubMed]Search in Google Scholar

29. Bermejo–Fenoll A, Sanchez–Siles M, López–Jornet P, et al. Premalignant nature of oral lichen planus. A retrospective study of 550 oral lichen planus patients from south–eastern Spain. Oral Oncol. 2009; 45: e54–e56. [PubMed]10.1016/j.oraloncology.2009.01.00919362039Search in Google Scholar

30. Taghavi Zenouz A, Mehdipour M, Attaran R, et al. Squamous cell carcinoma arising from an oral lichenoid lesion: a case report. J Dent Res Dent Clin Dent Prospects. 2012; 6: 29–32. [PMC free article][PubMed]Search in Google Scholar

31. Sugerman PB, Savage NW, Walsh LJ, et al. The pathogenesis of oral lichen planus. Critical Reviews in Oral Biology and Medicine. 2002; 13(4): 350–365. [PubMed]10.1177/15441113020130040512191961Search in Google Scholar

32. Farhi D, Dupin N. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clinics in Dermatology. 2010; 28(1): 100–108. [PubMed]10.1016/j.clindermatol.2009.03.00420082959Search in Google Scholar

33. Lodi G, Scully C, Carrozzo M, et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2005; 100(1): 40–51. [PubMed]10.1016/j.tripleo.2004.06.07715953916Search in Google Scholar

34. Gonzalez–Moles MA, Scully C, Gil–Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Diseases. 2008; 14(3): 229–243. [PubMed]10.1111/j.1601-0825.2008.01441.x18298420Search in Google Scholar

35. Ergun S, Troşala ŞC, Warnakulasuriya S, et al. Evaluation of oxidative stress and antioxidant profile in patients with oral lichen planus. Journal of Oral Pathology and Medicine. 2011; 40(4): 286–293. [PubMed]10.1111/j.1600-0714.2010.00955.x21039889Search in Google Scholar

36. Meek DW. The p53 response to DNA damage. DNA Repair. 2004; 3(8–9): 1049–1056. [PubMed]10.1016/j.dnarep.2004.03.02715279792Search in Google Scholar

37. Safadi RA, Jaber SZA, Hammad HM, Hamasha AAH. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study. Archives of Oral Biology. 2010; 55(6): 454–461.10.1016/j.archoralbio.2010.03.01920427035Search in Google Scholar

38. Sousa FA, Paradella TC, Carvalho YR, Rosa LE. Immunohistochemical expression of PCNA, p53, bax and bcl–2 in oral lichen planus and epithelial dysplasia. Journal of Oral Science. 2009; 51(1): 117–121.[PubMed]10.2334/josnusd.51.11719325208Search in Google Scholar

39. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP. Molecular analysis of oral lichen planus. Am J Pathol. 1997 Aug; 151(2): 323–327.Search in Google Scholar

40. Zhou XJ, Sugerman PB, Savage NW, Walsh LJ. Matrix metalloproteinases and their inhibitors in oral lichen planus. Journal of Cutaneous Pathology. 2001; 28(2): 72–82. [PubMed]10.1034/j.1600-0560.2001.280203.x11168755Search in Google Scholar

41. Rhodus NL, Cheng B, Myers S, Bowles W, Ho V, Ondrey F. A comparison of the pro–inflammatory, NF–κB–dependent cytokines: TNF–alpha, IL–1–alpha, IL–6, and IL–8 in different oral fluids from oral lichen planus patients. Clinical Immunology. 2005; 114(3): 278–283. [PubMed]10.1016/j.clim.2004.12.00315721838Search in Google Scholar

42. Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F. The feasibility of monitoring NF–κB associated cytokines: TNF–α, IL–1α, IL–6, and IL–8 in whole saliva for the malignant transformation of oral lichen planus. Molecular Carcino-genesis. 2005; 44(2): 77–82. [PubMed]10.1002/mc.20113Search in Google Scholar

43. Canavan C, Abrams KR, Mayberry J. Meta–analysis: colorectal and small bowel cancer risk in patients with Crohn’s disease. Alimentary Pharmacology and Therapeutics. 2006; 23(8): 1097–1104. [PubMed]10.1111/j.1365-2036.2006.02854.xSearch in Google Scholar

44. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population–based study. Cancer. 2001; 91(4): 854–862. [PubMed]10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-ZSearch in Google Scholar

45. Watanabe T, Ohishi M, Tanaka K, Sato H. Analysis of HLA antigens in Japanese with oral lichen planus. J Oral Pathol. 1986 Nov; 15(10): 529–33.10.1111/j.1600-0714.1986.tb00571.xSearch in Google Scholar

46. Колевски П. ХЛА–регија и болестите. Студентски збор, Скопје, 1987; 137–145.Search in Google Scholar

47. Simon M Jr, Djawari D, Schönberger A. HLA antigens associated with lichen planus. Clin Exp Dermatol. 1984 Jul; 9(4): 435.10.1111/j.1365-2230.1984.tb00833.xSearch in Google Scholar

48. Abreu Velez AM, Howard MS, Pereyo N. Palmar and plantar lichen planus: a case report and review of the literature. An Bras Dermatol. 2015 May–Jun; 90(3 Suppl 1): 175–7. doi: 10.1590/abd1806–4841.20153034. Review.10.1590/abd1806-4841.20153034Search in Google Scholar

49. Ognjenović M, Karelović D, Cindro VV, Tadin I. Oral lichen planus and HLA. A. Coll Antropol 1998; 22 Suppl: 89–92.Search in Google Scholar

50. Ognjenović M, Karelović D, Mikelić M, Tadin I, Vrebalov–Cindro V. Oral lichen planus and HLA. B. Coll Antropol 1998; 22 Suppl: 93–96.Search in Google Scholar

51. Ognjenović M, Karelović D, Cekić–Arambasin A, Tadin I, Vrebalov–Cindro V. Oral lichen planus and HLA DR. Coll Antropol 1998; 22 Suppl: 97–101.Search in Google Scholar

52. La Nasa G, Cottoni F, Mulargia M, Carcassi C, Vacca A, Pizzati A, et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Br J Dermatol 1995; 132: 897–900.10.1111/j.1365-2133.1995.tb16945.xSearch in Google Scholar

53. Ochoa BE, King LE, Price VH. Lichen planopilaris: annual incidence in four hair referral centers in the United States. J Am Acad Dermatol 2008; 58: 352–353.10.1016/j.jaad.2007.11.007Search in Google Scholar

54. Cevasco NC, Bergfeld WF, Remzi BK, de Knott HR. A case–series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol 2007; 57: 47–53.10.1016/j.jaad.2007.01.011Search in Google Scholar

55. Setterfield JF, Neill S, Shirlaw PJ, Theron J, Vaughan R, Escudier M, et al. The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele. J Am Acad Dermatol 2006; 55: 98–113.10.1016/j.jaad.2005.12.006Search in Google Scholar

56. Roitberg–Tambur A, Friedmann A, Korn S, Markitziu A, Pisanti S, Safirman C, et al. Sero-logic and molecular analysis of the HLA system in Israeli Jewish patients with oral erosive lichen planus. Tissue Antigens 1994; 43: 219–223.10.1111/j.1399-0039.1994.tb02328.xSearch in Google Scholar

57. White AG, Rostom AI. HLA antigens in Arabs with lichen planus. Clin Exp Dermatol 1994; 19: 236–237.10.1111/j.1365-2230.1994.tb01174.xSearch in Google Scholar

58. Porter K, Klouda P, Scully C, Bidwell J, Porter S. Class I and II HLA antigens in British patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1993; 75: 176–180.10.1016/0030-4220(93)90090-QSearch in Google Scholar

59. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007; 117: 2019–2027.10.1172/JCI31942193457417671634Search in Google Scholar

60. Megiorni F, Pizzuti A, Mora B, Rizzuti A, Garelli V, Maxia C, et al. Genetic association of HLA– DQB1 and HLA–DRB1 polymorphisms with alopecia areata in the Italian population. Br J Dermatol 2011; 165: 823–827.10.1111/j.1365-2133.2011.10466.x21692766Search in Google Scholar

61. Pavlovsky L, Israeli M, Sagy E, Berg AL, David M, Shemer A, Klein T, Hodak E. Lichen planopilaris is associated with HLA DRB1*11 and DQB1*03 alleles. Acta Derm Venereol. 2015 Feb; 95(2): 177–80. doi: 10.2340/00015555–1884.10.2340/00015555-188424806356Search in Google Scholar

62. Akbar AN Timms A, Janossy G.Cellular events during memory T–cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis. Immunology. 1989 Feb; 66(2): 213–8.Search in Google Scholar

63. Telagi N, Ahmed Mujib BR, Kulkarni PG2, Naik R.The master switch: Comparative study of mast cell in oral epithelial dysplasia, oral submucousfibrosis and oral squamous cells carcinoma and their association with inflammation and angio-genesis. J Oral Maxillofac Pathol. 2015 Jan–Apr; 19(1): 25–9. doi: 10.4103/0973-029X.157196.10.4103/0973-029X.157196445166126097302Search in Google Scholar

64. Akbar AN Timms A, Janossy G.Cellular events during memory T–cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis. Immunology. 1989 Feb; 66(2): 213–8.Search in Google Scholar

Empfohlene Artikel von Trend MD

Planen Sie Ihre Fernkonferenz mit Scienceendo